Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
25.87
+0.19 (0.74%)
Jan 2, 2026, 11:21 AM EST - Market open
Progyny Market Cap
Progyny has a market cap or net worth of $2.23 billion as of January 2, 2026. Its market cap has increased by 79.27% in one year.
Market Cap
2.23B
Enterprise Value
1.90B
1-Year Change
79.27%
Ranking
Category
Stock Price
$25.87
Market Cap Chart
Since October 25, 2019, Progyny's market cap has increased from $1.31B to $2.23B, an increase of 70.27%. That is a compound annual growth rate of 8.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 2.21B | 50.72% |
| Dec 31, 2024 | 1.47B | -58.78% |
| Dec 29, 2023 | 3.56B | 23.15% |
| Dec 30, 2022 | 2.89B | -36.45% |
| Dec 31, 2021 | 4.55B | 23.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |